Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Susan S. Esty"'
Publikováno v:
Immunohematology. 10:90-94
The 51chromium (51Cr) red cell recovery study is a reliable measure of transfusion compatibility. However, the monocyte monolayer assay (MMA) does not require the use of radioactive isotopes or the injection of incompatible RBCs. In this study, 51Cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca50a51a450940b92994c6dde855c38f
https://doi.org/10.21307/immunohematology-2019-929
https://doi.org/10.21307/immunohematology-2019-929
Autor:
Mary B. Leatherbarrow, Deborah K. Douglas, Robert J. Eckrich, M. L. Baldwin, Susan S. Esty, Patricia A. Collins, Paul M. Ness, Sandra S. Ellisor
Publikováno v:
Immunohematology. 4:71-74
An alloantibody to a high-incidence antigen, associated with multiple other alloantibodies, made it impossible to supply antigen-negative red blood cells (RBCs) for a chronically transfused sickle cell anemia patient. Anti-Cra,-E,K,-S, -Fya, -Fyb, as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce61a0a4de7837bbd6aba1fee30047f0
https://doi.org/10.21307/immunohematology-2019-1108
https://doi.org/10.21307/immunohematology-2019-1108
Publikováno v:
Immunohematology. 3:6-9
The survival of red blood cells (RBCs) radiolabeled with 51chromium (51Cr) is a reliable method for predicting transfusion compatibility. Approximately 1.0 ml of 51Cr tagged RBCs is infused into the patient and samples are drawn at predetermined inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9b93a6c559bda0cac126dc9d6358569
https://doi.org/10.21307/immunohematology-2019-1119
https://doi.org/10.21307/immunohematology-2019-1119